Sign In
Buy ABT
$90.51
-0.0200 (-0.0221%)
At Close: Jun 24, 2026
Abbott faces U.S. criminal probe over baby formula -WSJ
06:36pm, Friday, 20'th Jan 2023
Abbott Laboratories' Michigan plant, which was at the center of the U.S. baby formula shortage last year, is being investigated by the Justice Department, the Wall Street Journal reported on Friday.
Abbott facing criminal investigation over baby-formula plant operations
06:26pm, Friday, 20'th Jan 2023
The Justice Department is investigating conduct at the Abbott Laboratories infant-formula plant in Sturgis, Mich., that led to its shutdown last year and worsened a nationwide formula shortage, people
Abbott Under Criminal Investigation Over Baby Formula
06:06pm, Friday, 20'th Jan 2023
Federal prosecutors are probing conduct at Abbott's baby-formula plant in Michigan, which the company temporarily shutdown last year after a potentially deadly bacteria was found
Why Abbott (ABT) is Poised to Beat Earnings Estimates Again
01:32pm, Friday, 20'th Jan 2023
Abbott (ABT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
3 Top Passive-Income Stocks to Own in 2023
02:00pm, Thursday, 19'th Jan 2023
These stocks can add safety and growth to your portfolio.
10 Biggest Companies Reporting Earnings in the 4th Week of Jan 2023
10:52pm, Wednesday, 18'th Jan 2023
The fourth quarter earnings season is always the most important because it reveals the full year performance of the companies as well.
My Dividend Growth Portfolio - Q4 2022 Summary
01:23am, Wednesday, 18'th Jan 2023
In 2015, I started publishing updates regarding my dividend growth portfolio, and I keep doing so every quarter. This is part of being transparent with my readers, so they can see what I hold and its
What's in Store for Abbott Laboratories (ABT) in Q4 Earnings?
09:47am, Tuesday, 17'th Jan 2023
Within Abbott's (ABT) Established Pharmaceuticals Division (EPD), new product launches across key markets have been majorly boosting business in recent months.
Abbott (ABT) Stock Sinks As Market Gains: What You Should Know
10:50pm, Thursday, 12'th Jan 2023 Zacks Investment Research
In the latest trading session, Abbott (ABT) closed at $111.36, marking a -1.58% move from the previous day.
Zoetis, SL Green Realty, Abbott Laboratories And This Big Bank Reporting Earnings On Friday: CNBC's 'Final Trades'
02:25pm, Thursday, 12'th Jan 2023 Benzinga
On CNBC’s "Halftime Report Final Trades," Brenda Vingiello of Sand Hill Global Advisors named Zoetis Inc. (NYSE: ZTS) as her final trade.
Jenny Harrington of Gilman Hill Asset Management said
Should You Buy This Promising New Healthcare Stock?
11:42am, Thursday, 12'th Jan 2023 The Motley Fool
Shares of GE Healthcare began trading last week after the company completed its spinoff from General Electric.
Final Trades: Abbott Labs, SL Green, Zoetis & more
02:52pm, Wednesday, 11'th Jan 2023
The "Halftime Report" traders give their top picks to watch for the second half.
3 Supercharged Dividend Stocks to Buy If There's a Stock Market Sell-Off
12:50pm, Wednesday, 11'th Jan 2023 The Motley Fool
These three healthcare stocks all deliver dependable dividends, with yields of 3% or more.
Abbott Laboratories (ABT) 41st Annual J.P. Morgan Healthcare Conference (Transcript)
02:04pm, Tuesday, 10'th Jan 2023
Abbott Laboratories (NYSE:ABT ) 41st Annual J.P. Morgan Healthcare Conference January 10, 2023 12:00 PM ET Company Participants Robert Ford - Chairman and Chief Executive Officer Conference Call Parti
Imported baby formula is about to get expensive again, with tariffs back in place
03:54am, Tuesday, 10'th Jan 2023 MarketWatch
Product recalls from Abbott Laboratories last February exacerbated an infant-formula shortage caused by supply-chain disruptions.
